Markets:

Overview

News

Currencies

International

Treasuries

Absci Corporation - Common Stock (NQ:ABSI)

11.62 +0.03 (+0.22%)

Streaming Delayed Price Updated: 9:55 AM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Absci Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Peering Into Absci's Recent Short Interest ↗

January 31, 2025

Via Benzinga

Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗

January 17, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

February 18, 2025

From Absci Corporation

Via GlobeNewswire

What's going on in today's after hours session ↗

February 17, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗

January 22, 2025

Via Benzinga

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside ↗

January 22, 2025

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and $9 price target.

Via Benzinga

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings ↗

January 22, 2025

Via Benzinga

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

January 22, 2025

From Absci Corporation

Via GlobeNewswire

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

January 22, 2025

Via Benzinga

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies ↗

January 22, 2025

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Via Benzinga

Topics Government

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

January 10, 2025

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class...

From Absci Corporation; Owkin

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday ↗

January 08, 2025

Via Benzinga

Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery ↗

January 08, 2025

Absci shares are rising after announcing a strategic collaboration with Advanced Micro Devices Inc. The partnership will enhance Absci's AI drug discovery capabilities using AMD Instinct accelerators...

Via Benzinga

Topics Artificial Intelligence

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

January 08, 2025

$20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm Software

From Absci Corporation

Via GlobeNewswire

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

January 06, 2025

Collaboration leverages Absci’s leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health applications

From Absci Corporation; Invetx

Via GlobeNewswire

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 02, 2025

From Absci Corporation

Via GlobeNewswire

Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day

December 12, 2024

From Absci Corporation

Via GlobeNewswire

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2024

Via Benzinga

United Natural Foods Posts Upbeat Results, Joins Alphabet, Ollie's Bargain, MoneyLion And Other Big Stocks Moving Higher On Tuesday ↗

December 10, 2024

Via Benzinga

Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference

November 21, 2024

From Absci Corporation

Via GlobeNewswire

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

November 12, 2024

From Absci Corporation

Via GlobeNewswire

Absci to Host R&D Day on December 12, 2024

November 07, 2024

From Absci Corporation

Via GlobeNewswire

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI

October 31, 2024

Collaboration brings together Absci’s Generative AI drug creation platform with Twist’s DNA synthesis platform to accelerate the design of a novel therapeutic antibody

From Absci Corporation

Via GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

October 24, 2024

From Absci Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.